Neptune Medical
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | N/A | - | |
N/A | N/A | - | |
* | $97.0m | Series D | |
Total Funding | €88.2m |
Recent News about Neptune Medical
EditPathfinder is a pioneering medical device company specializing in the development of a novel rigidizing overtube designed to improve the control and stability of endoscopes during gastrointestinal (GI) procedures. The company's primary product, the Pathfinder overtube, addresses the common issue of loop formation in endoscopic procedures, which can complicate and prolong diagnostic and therapeutic interventions. By allowing the overtube to toggle instantly from flexible to rigid, Pathfinder enhances the precision and ease of endoscope navigation, making it particularly valuable in complex cases involving altered anatomy.
Pathfinder serves healthcare providers and medical professionals who perform GI procedures, including luminal therapeutics and Endoscopic Retrograde Cholangiopancreatography (ERCP). The company operates within the medical device market, focusing on innovations that improve procedural outcomes and patient care. Pathfinder's business model revolves around the sale of its overtube devices to hospitals, clinics, and medical centers, generating revenue through direct sales and potential partnerships with medical equipment distributors.
The company's value proposition lies in its ability to simplify traditionally complex GI procedures, reduce procedural time, and enhance the overall effectiveness of endoscopic interventions. By providing a reliable solution to the problem of endoscope looping, Pathfinder aims to improve the efficiency and success rates of GI procedures, ultimately benefiting both healthcare providers and patients.
Keywords: rigidizing overtube, endoscope control, GI procedures, loop prevention, medical device, healthcare innovation, procedural efficiency, luminal therapeutics, ERCP, endoscopic navigation.